Literature DB >> 2973229

Improved predictive testing for Huntington disease by using three linked DNA markers.

M R Hayden1, C Robbins, D Allard, J Haines, S Fox, J Wasmuth, M Fahy, M Bloch.   

Abstract

Eighty-five persons at risk for Huntington disease (HD) have enrolled in a predictive-testing pilot program. Informativeness of the test has been determined for 41 of these candidates by using linked DNA probes. Nine (21.9%) of these persons have been excluded from the test as a result of the unavailability of DNA from crucial family relatives. Homozygosity for all of the three DNA markers (D4S10, D4S62, and D4S95) was not found in any affected parent. Only one (2%) of the 41 test candidates has had an uninformative result. Results have been given to 20 persons, of whom 12 (60%) received a decreased risk and eight (40%) received an increased risk of having inherited the mutant gene for HD. The combined use of three DNA markers significantly increases the informativeness of family structures such that some change in the estimation of genetic risk is now possible for approximately 75% of all persons who request predictive testing.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2973229      PMCID: PMC1715530     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  10 in total

1.  Genetic prediction and family structure in Huntington's chorea.

Authors:  P S Harper; M Sarfarazi
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-29

2.  A polymorphic DNA marker that represents a conserved expressed sequence in the region of the Huntington disease gene.

Authors:  M R Hayden; J Hewitt; J J Wasmuth; J J Kastelein; S Langlois; M Conneally; J Haines; B Smith; C Hilbert; D Allard
Journal:  Am J Hum Genet       Date:  1988-01       Impact factor: 11.025

3.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

4.  Huntington disease: estimation of heterozygote status using linked genetic markers.

Authors:  P M Conneally; M R Wallace; J F Gusella; N S Wexler
Journal:  Genet Epidemiol       Date:  1984       Impact factor: 2.135

5.  First-trimester prenatal diagnosis for Huntington's disease with DNA probes.

Authors:  M R Hayden; J Hewitt; J J Kastelein; S Langlois; R D Wilson; S Fox; C Hilbert; M Bloch
Journal:  Lancet       Date:  1987-06-06       Impact factor: 79.321

6.  Exclusion testing for Huntington's disease in pregnancy with a closely linked DNA marker.

Authors:  O W Quarrell; A L Meredith; A Tyler; S Youngman; M Upadhyaya; P S Harper
Journal:  Lancet       Date:  1987-06-06       Impact factor: 79.321

7.  DNA polymorphisms in and around the Apo-A1-CIII genes and genetic hyperlipidemias.

Authors:  M R Hayden; H Kirk; C Clark; J Frohlich; S Rabkin; R McLeod; J Hewitt
Journal:  Am J Hum Genet       Date:  1987-05       Impact factor: 11.025

8.  A DNA segment encoding two genes very tightly linked to Huntington's disease.

Authors:  T C Gilliam; M Bucan; M E MacDonald; M Zimmer; J L Haines; S V Cheng; T M Pohl; R H Meyers; W L Whaley; B A Allitto
Journal:  Science       Date:  1987-11-13       Impact factor: 47.728

9.  Predictive testing for Huntington's disease with use of a linked DNA marker.

Authors:  G J Meissen; R H Myers; C A Mastromauro; W J Koroshetz; K W Klinger; L A Farrer; P A Watkins; J F Gusella; E D Bird; J B Martin
Journal:  N Engl J Med       Date:  1988-03-03       Impact factor: 91.245

10.  A highly polymorphic locus very tightly linked to the Huntington's disease gene.

Authors:  J J Wasmuth; J Hewitt; B Smith; D Allard; J L Haines; D Skarecky; E Partlow; M R Hayden
Journal:  Nature       Date:  1988-04-21       Impact factor: 49.962

  10 in total
  18 in total

1.  Studies on DNA markers (D4S10 and D4S43/S127) genetically linked to Huntington's disease in Japanese families.

Authors:  I Kanazawa; I Kondo; J E Ikeda; T Ikeda; Y Shizu; M Yoshida; H Narabayashi; S Kuroda; H Tsunoda; E Mizuta
Journal:  Hum Genet       Date:  1990-08       Impact factor: 4.132

2.  Presymptomatic Diagnosis of Genetic Disorders: Is it worth the anxiety?

Authors:  T N Tannenbaum; E E Rosenberg
Journal:  Can Fam Physician       Date:  1991-02       Impact factor: 3.275

3.  Clinical consequences of isolating the gene for Huntington's disease.

Authors:  P S Harper
Journal:  BMJ       Date:  1993-08-14

4.  Risk reversals in predictive testing for Huntington disease.

Authors:  E Almqvist; S Adam; M Bloch; A Fuller; P Welch; D Eisenberg; D Whelan; D Macgregor; W Meschino; M R Hayden
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

5.  Non-random association between alleles detected at D4S95 and D4S98 and the Huntington's disease gene.

Authors:  J Theilmann; S Kanani; R Shiang; C Robbins; O Quarrell; M Huggins; A Hedrick; B Weber; C Collins; J J Wasmuth
Journal:  J Med Genet       Date:  1989-11       Impact factor: 6.318

6.  Attitudes of general practitioners to presymptomatic testing for Huntington's disease.

Authors:  M E Mennie; S M Holloway; D J Brock
Journal:  J Med Genet       Date:  1990-04       Impact factor: 6.318

7.  Opinion: predictive testing for Huntington disease in childhood: challenges and implications.

Authors:  M Bloch; M R Hayden
Journal:  Am J Hum Genet       Date:  1990-01       Impact factor: 11.025

8.  Linkage disequilibrium and modification of risk for Huntington disease.

Authors:  S Adam; J Theilmann; K Buetow; A Hedrick; C Collins; B Weber; M Huggins; M Hayden
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

9.  Presymptomatic testing for Huntington's disease in the United Kingdom. The United Kingdom Huntington's Disease Prediction Consortium.

Authors:  A Tyler; D Ball; D Craufurd
Journal:  BMJ       Date:  1992-06-20

Review 10.  Huntington's disease and the ethics of genetic prediction.

Authors:  G Terrenoire
Journal:  J Med Ethics       Date:  1992-06       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.